Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ATM/ATR
    (8)
  • Apoptosis
    (6)
  • Autophagy
    (4)
  • MDM-2/p53
    (4)
  • Bcl-2 Family
    (3)
  • Caspase
    (3)
  • PROTACs
    (3)
  • Antibacterial
    (2)
  • Microtubule Associated
    (2)
  • Others
    (14)
TargetMol | Tags By Natures
  • Isodon
    (1)
  • Punica
    (1)
  • Rheum
    (1)
  • Zingiber
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (18)
  • Infection
    (3)
  • Nervous System
    (2)
  • Endocrine system
    (1)
  • Metabolism
    (1)
  • Respiratory System
    (1)
Filter
Search Result
Results for "

lovo

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    32
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • PROTAC Products
    5
    TargetMol | PROTAC
  • Natural Products
    5
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Cell Research
    3
    TargetMol | Cell_Research_Reagents
  • Thiocolchicine
    T412482730-71-4
    Thiocolchicine is an effective inhibitor of tubulin polymerization with an IC50 of 2.5 µM and a Ki of 0.7 µM. Thiocolchicine induces cell apoptosis. Thiocolchicine can be used as an ADC cytotoxin in ADC technology.
    • $40
    In Stock
    Size
    QTY
  • E7820
    ER68203-00
    T4435289483-69-8
    E7820 (ER68203-00) is an angiogenesis inhibitor by suppressing integrin a2 (a cell adhesion molecule expressed on endothelial cells).
    • $30
    In Stock
    Size
    QTY
  • Clovoxamine
    DU-23811, DU23811, DU 23811
    T2704754739-19-4In house
    Clovoxamine (DU 23811) is a 5-hydroxytryptamine reuptake, serotonin and norepinephrine inhibitor with antidepressant and anticonvulsant activity.
    • $293 TargetMol
    In Stock
    Size
    QTY
  • β-Glucosidase 1A, Clostridium cellulovorans
    TRP-01218
    β-Glucosidase 1A from Clostridium cellulovorans (EC 3.2.1.21) is an enzyme that targets the β1→4 glycosidic bond between two glucose molecules or glucose-substituted molecules, such as the disaccharide cellobiose. As a member of the cellulase family, β-Glucosidase participates in the breakdown of cellulose and related polysaccharides. Specifically, it functions as an exocellulase, displaying specificity for various β-D-glycoside substrates by catalyzing the hydrolysis of terminal, non-reducing β-D-glucoside residues, thereby releasing glucose.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • β-Mannanase 26B, Clostridium cellulovorans
    TRP-01402
    β-Mannanase 26B, Clostridium cellulovorans (EC 3.2.1.78), is an enzyme that functions as a 4-β-D-mannan mannohydrolase. It catalyzes the random hydrolysis of (1->4)-β-D-mannosidic linkages in mannans, galactomannans, and glucomannans.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • β-Mannanase 5A, Clostridium cellulovorans
    TRP-01410
    β-Mannanase 5A, Clostridium cellulovorans (EC 3.2.1.78), is an enzyme classified as a 4-β-D-mannan mannohydrolase. It catalyzes the random hydrolysis of (1->4)-β-D-mannosidic linkages in mannans, galactomannans, and glucomannans.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Punicalagin
    T392165995-63-3
    Punicalagin is a major ellagitannin found in pomegranates that is reported to produce antioxidant, anti-inflammatory, and anticancer effects. It has been shown to prevent high-fat diet-induced obesity-associated accumulation of cardiac triglyceride and ch
    • $38
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Curcumin
    Turmeric yellow, Natural Yellow 3, Indian Saffron, Diferuloylmethane
    T1516458-37-7
    Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 μM) with specificity. Curcumin has a wide range of pharmacological activities such as antitumor, anti-inflammatory and antioxidant.
    • $37
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Emodin
    Frangula emodin
    T2869518-82-1
    Emodin (Frangula emodin) is an 11β-HSD1 inhibitor with a selective IC50 of 186 and 86 nM against 11β-HSD1 in humans and mice, respectively. Emodin has antiviral, anti-inflammatory, and anti-cancer effects. Emodin can improve metabolic disorders in diet-induced obese mice.
    • $45
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Decylubiquinone
    6-Decylubiquinone
    T2713955486-00-5
    Decylubiquinone (DUb) is a coenzyme Q10 analog with anticancer activity, inhibiting breast cancer growth and metastasis, enhancing mitochondrial function in synaptosomes, and inhibiting tumor-induced angiogenesis.
    • $118
    In Stock
    Size
    QTY
  • EV206
    T2008852247047-81-8
    EV206 is a potent Hsp70 inhibitor, demonstrating significant anti-proliferative activity. This compound induces apoptosis and promotes increased protein expression of cleaved PARP and caspase-3, indicating its potential anti-tumor activity.
    • $68
    In Stock
    Size
    QTY
  • WEE1-IN-10
    T893652226938-19-6
    WEE1-IN-10 (compound 77) is a Wee1 kinase inhibitor that inhibits the growth of LOVO cells (IC50=0.524 μM) and can be used to study diseases caused by abnormal Wee1 activity, such as pancreatic cancer, malignant melanoma, and malignant glioma.
    • $75
    In Stock
    Size
    QTY
  • Veonetinib
    T2008311210828-09-3
    Veonetinib (example 3) is an effective inhibitor of tyrosine kinase , exhibiting IC50 values of 0.1 μM and 0.4 μM in A549 cells and LOVO cells, respectively.
    • Inquiry Price
    3-6 months
    Size
    QTY
  • PROTAC PARP1 degrader-3
    T203470
    PROTAC PARP1 degrader-3 (Compound C6) is a PROTAC degrader specifically targeting PARP1, with a DC50 of 58.14 nM. It demonstrates cytotoxicity in SW-620 and LOVO cancer cells, with IC50 values of 1.63 μM and 2.84 μM, respectively. In BRCA-mutated colon cancer cells, PROTAC PARP1 degrader-3 exhibits synergistic effects with SN-38, with a combination index (CI) of 0.487.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • CDK1-IN-7
    T207488933009-51-9
    CDK1-IN-7 (compound M7) is a potent CDK1 inhibitor. It effectively suppresses the proliferation and migration of HCT116 and Lovo cells, making it a valuable tool for colorectal cancer research.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • SHP2 protein degrader-3
    T211874
    SHP2protein degrader-3 is an AUTAC protein degrader specifically targeting SHP2. It induces dose-dependent degradation of SHP2 in HeLa cells, with a DC50 of 3.22 μM, and demonstrates significant antitumor activity with an IC50 of 5.59 μM. The degradation mechanism is mediated via LC3-dependent autophagy, which can be inhibited by lysosomal inhibitors. SHP2protein degrader-3 also induces apoptosis in various tumor cell lines, including cervical cancer cells (HeLa), liver cancer cells (HepG2 and Huh-7), and colon cancer cells (LoVo). [SHP2ligand: ; LC3 Ligand: ; Linker: .]
    • Inquiry Price
    Inquiry
    Size
    QTY
  • ATR-IN-32
    T2135772902715-97-1
    ATR-IN-32 is an orally active ATR inhibitor that effectively suppresses the proliferation of MIA PaCa-2 cells. It significantly inhibits tumor growth in mice bearing LOVO and HT-29 xenografts. ATR-IN-32 is applicable for studying cancers mediated by the ATR protein kinase, such as colorectal cancer and pancreatic cancer.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Tubulin-IN-56
    T213625
    Tubulin-IN-56 is a tubulin inhibitor with cytotoxic effects on colon cancer cell lines (LS180, HCT116, SW620, LoVo). It downregulates βIII-tubulin expression and upregulates βIVa-tubulin expression within these cell lines. Additionally, Tubulin-IN-56 inhibits cell invasiveness and elevates intracellular ROS levels in colon cancer cell lines. This compound is applicable in colon cancer research.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • PROTAC ATR degrader-3
    T218372
    PROTAC ATRdegrader-3 is a potent CRBN-based ATR PROTAC degrader with a DC50 of 127 nM. This compound also degrades CHK1, with a corresponding DC50 of 135 nM. PROTAC ATRdegrader-3 inhibits the proliferation, migration, and invasion of cancer cells, induces apoptosis, and causes S phase arrest and DNA damage. It effectively suppresses tumor growth in LoVo xenograft mouse models with negligible toxicity. PROTAC ATRdegrader-3 is applicable in research related to colorectal cancer.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • 2,3-DCPE
    T22490418788-90-6
    Induces p21 expression and S-phase arrest in cancer cells via ERK-mediated pathways. IC50 values are 0.89 and 12.6 μM for LoVo human colon cancer cell line and normal human fibroblasts respectively.
    • $1,520
    6-8 weeks
    Size
    QTY
  • Pestalotin
    T3688634565-32-7
    Pestalotin is a fungal metabolite originally isolated from P. cryptomeriaecola with diverse biological activities. It induces reducing sugar release in embryoless rice endosperms when used at concentrations ranging from 3 to 100 mg/L and enhances growth of rice seedlings (O. sativa) when used in combination with gibberellin A3 at concentrations ranging from 30 to 500 mg/L. Pestalotin has antifungal activity, reducing the growth of C. albicans, C. neoformans, T. rubrum, and A. fumigatus (MICs = 12.5, 50, 50, and 50 μg/ml, respectively). It is cytotoxic to HL-60, MKN45, LoVo, and A549 cells (IC50s = 64.87-182.92 μM). Pestalotin has been used as a standard for dereplication of natural products.
    • $2,565
    Inquiry
    Size
    QTY
  • ATR-IN-16
    T614322756589-62-3
    ATR-IN-16 (compound 46) is a potent ATR kinase inhibitor with significant anticancer activity in LoVo cells, as evidenced by an IC50 value of 410 nM [1].
    • $1,520
    6-8 weeks
    Size
    QTY
  • ATR-IN-15
    T615872756665-52-6
    ATR-IN-15 (compound 1) is a highly potent, orally active ATR kinase inhibitor with an IC50 of 8 nM. It also exhibits inhibitory activity against human colon tumor cells LoVo, DNA-PK, and PI3K, with IC50 values of 47, 663, and 5131 nM, respectively [1].
    • $1,520
    6-8 weeks
    Size
    QTY
  • ATR-IN-14
    T618082765785-88-2
    ATR-IN-14 (compound 1) is a powerful ATR kinase inhibitor that significantly inhibits ATR signaling pathways following CHKI protein phosphorylation, with a remarkable inhibition rate of 98.03% at 25 nM. ATR-IN-14 also exhibits notable anticancer efficacy in LoVo cells, displaying an IC50 value of 64 nM [1].
    • $1,520
    10-14 weeks
    Size
    QTY